RNU7-22P

Across TCGA pan-cancer cohorts, RNU7-22P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-22P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU7-22P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-22P expression acts as an unfavorable survival marker.

BRCA, KIRC, and ESCA are the cancer types where RNU7-22P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.336	0.924	<.001	72	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
STAD	DFS	Tertile	All	0.444	0.722	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-22P–BRCA (OS)

Open the BRCA breakdown →